Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
2.720
-0.050 (-1.81%)
Aug 14, 2025, 9:25 AM - Market open
BDTX Stock Forecast
Stock Price Forecast
According to 5 professional analysts, the 12-month price target for BDTX stock ranges from a low of $10 to a high of $16. The average analyst price target of $13.4 forecasts a 392.65% increase in the stock price over the next year.
Price Target: $13.40 (+392.65%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BDTX stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 4 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $10 | Strong Buy | Maintains | $12 → $10 | +267.65% | Aug 11, 2025 |
| Raymond James | Raymond James | Buy Initiates $11 | Buy | Initiates | $11 | +304.41% | Jul 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $12 | Strong Buy | Maintains | $11 → $12 | +341.18% | Mar 18, 2025 |
| Stifel | Stifel | Strong Buy Maintains $16 → $15 | Strong Buy | Maintains | $16 → $15 | +451.47% | Mar 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +304.41% | Nov 6, 2024 |
Financial Forecast
Revenue This Year
71.40M
Revenue Next Year
n/a
from 71.40M
EPS This Year
0.25
from -1.27
EPS Next Year
-1.04
from 0.25
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 73.5M | n/a | 20.9M | ||
| Avg | 71.4M | n/a | 6.8M | ||
| Low | 68.6M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.28 | -0.84 | -0.81 | ||
| Avg | 0.25 | -1.04 | -1.21 | ||
| Low | 0.22 | -1.42 | -1.96 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.